Treatment preferences by infectious diseases clinicians for carbapenem-resistant Enterobacterales infections
Most clinicians selected antibiotics aligned with the IDSA guidance for serious CRE infections, although the frequent selection of an agent not in the guidance for uncomplicated cystitis suggests that treatment selection is complex and may depend on infection severity, among other factors. The preference for ceftazidime-avibactam among similar agents is notable and may reflect its longer market availability.
Authors
- Susan E. Beekmann (ORCID: https://orcid.org/0000-0003-0278-506X)
- Samuel E Cincotta (ORCID: https://orcid.org/0000-0001-6872-1216)
- Philip M. Polgreen (ORCID: https://orcid.org/0000-0002-0630-5898)
- Belinda Ostrowsky
- Maroya Spalding Walters (ORCID: https://orcid.org/0000-0002-1090-7621)
- Jessica Howard‐Anderson (ORCID: https://orcid.org/0000-0001-9924-0458)
Institutions
- University of Iowa (US)
- Centers for Disease Control and Prevention (US)
- Emory University (US)
- Woodruff Health Sciences Center (US)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1093/jac/dkaf371
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00